logo

IOBT

IO Biotech·NASDAQ
--
--(--)
--
--(--)
3.81 / 10
Netural

Analyst sentiment is neutral, with one report labeling the stock 'Neutral' and no historical wins (0.0% win rate). Money flow, however, is positive with a 7.62/10 score; block, small, medium, large, and extra-large inflows all trend positively, hinting at institutional accumulation despite the recent sell-off. This divergence between neutral analyst views and robust fund inflows adds complexity to the near-term outlook.

FundamentalSentiment(3.81)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

0%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-26
InstitutionPiper Sandler
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for IOBT?
  • IOBT holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.81/10 (Netural).